pharmaphorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. We talk a lot in clinical trials and drug development about benefit,” Dr Mullen said. But who is benefitting?

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 111

pharmaphorum

AUGUST 27, 2020

Over the past five to ten years US investors have focused on technology and internet companies, and relatively little on new biotech or pharmaceutical companies. As a result, the FTSE 350 Pharmaceuticals & Biotech index hit all-time highs in May. Investment trends in the US influence investor appetite in the UK.

Vaccines 122

Vaccines Drug Pricing Compounding Immunization 122

Pharmaceutical Technology

JUNE 5, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 40

pharmaphorum

NOVEMBER 2, 2020

The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement the most cutting-edge technologies. This knowledge is critical in understanding how effective certain drugs might be in treating the virus. What’s on the horizon?

Vaccines 132

Vaccines Drug Development Diabetes Immunization 132

PharmaShots

MAY 9, 2023

Sit back and relax, while the article unfolds before you, the magic model that is certain to revamp your company Achieving economic sustenance and ensuring smooth sailing even in unfavorable situations are two common dreams that every pharmaceutical company shares.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Drug Development Drug Pricing 56

Pharmaceutical Technology

SEPTEMBER 26, 2022

GlobalData’s Contract Service Provider database shows that Novartis has 25 manufacturing sites in the US, Europe and China, including five API biologics (cell, gene, vaccine and virus) facilities in the US, France and Switzerland. These highlight the parent company’s focus on innovative and high-value drug development.

Biosimilars 64

Biosimilars Drug Development Vaccines Dosage 64

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. However, recent advancements in research have resulted in new drugs that show promising results in slowing the progression of the disease.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

pharmaphorum

OCTOBER 28, 2020

Data defines modern therapeutics, but this is almost uniquely confined to the clinical trial stages of drug development. Identifying, recruiting, retaining and monitoring patients during this part of the cycle is estimated to cost pharma US$19 billion a year as companies seek to harvest patient experiences.

Vaccines 119

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 119

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. Delivering value for patients doesn’t start and end in our R&D labs; actions can be implemented across all stages of the drug development lifecycle to encourage and embrace a pro-innovation environment.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

Pharma Marketing Network

MAY 11, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. However, recent advancements in research have resulted in new drugs that show promising results in slowing the progression of the disease.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

Viseven

SEPTEMBER 18, 2024

When COVID hit, the urgent need to accelerate drug development meant shrinking timelines from years to months, with no room for compromises on quality. Cloud-based tools allowed pharma companies to capture and share clinical data between research teams both securely and quickly.

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 12, 2022

“We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says. Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines.

Drug Development 105

Drug Development Immunization Immunity Vaccines 105

PharmaShots

FEBRUARY 20, 2023

After the outbreak of any epidemic or pandemic, all the responsibilities come on the shoulders of pharmaceutical companies. With unprecedented diseases lurking on the corner, pharmaceutical companies, are now obligated to widen their conventional horizons and look for substitute practices in their drug development strategies.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 40

European Pharmaceutical Review

JANUARY 16, 2023

” Tony Cundell: Contract manufacturing organisations (CROs), start-up companies, established pharmaceutical companies and regulatory agencies are having difficulty recruiting and retaining technically-trained personnel. The previous record for vaccine development and approval was four years for the measles vaccine.

Vaccines 128

Vaccines Research Laboratories Documentation Compounding 128

Pharmaceutical Technology

MARCH 9, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Hospitals 52

Hospitals Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharmaceutical Technology

DECEMBER 9, 2022

M&A – Commended PRODUCT LAUNCHES – Commended RESEARCH AND DEVELOPMENT – Commende d. Pharmaceutical Technology Excellence Rankings – The Verdict. Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing. HQ ADDRESS: Römerpark 2.

Vaccines 52

Vaccines Biosimilars Compounding Packaging 52

Pharmaceutical Technology

NOVEMBER 4, 2022

For the pharmaceutical industry, disorder in the supply chain can be catastrophic especially when it comes to life saving and sustaining drugs. Global shortages of critical drugs are a growing issue, as demonstrated by the recent challenges around cold chains for COVID vaccines. The CMO solution. Time to evolve.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

Express Pharma

JULY 10, 2024

India has traced a journey of grit and glory to emerge as a major supplier of generic drugs and vaccines globally. IBER Report 2023 divulges, “The biopharma vaccines (non-COVID alone) market makes a significant daily contribution of approximately $38 million. Today, it is a key player in the global pharma landscape.

Vaccines 83

Vaccines Drug Development Process Improvement Biosimilars 83

The Digital Apothecary

MAY 13, 2017

As a pharmacy educator, I love the history of drug development for instance, and in every discussion, I have with students, whether in the classroom or small groups, I like to frame our current understanding of what we are doing based on what we used to do.

Diabetes 130

Diabetes Vaccines Pharmaceutical Companies Pharmaceutical Companies 130

pharmaphorum

JULY 1, 2021

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm’s Tanja Dowe. The next decade is where it really starts to get interesting, as we see more and more ‘synbio’-enabled drugs enter clinical trials.

Drug Development 85

Drug Development Pharmaceutical Companies Pharmaceutical Companies Vaccines 85

pharmaphorum

MARCH 30, 2021

“There’s a lot that drug development for more common diseases could learn from rare disease R&D”. I think there’s a lot that drug development for more common diseases could learn from rare disease R&D.”. We have to be innovative to get around those challenges. Rare diseases during COVID.

Hospitals 111

Hospitals Communication Drug Development Pharmaceutical Companies 111

pharmaphorum

SEPTEMBER 9, 2021

The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development. COVID-19 also put global supply chains in the spotlight, as industry looked to remove obstacles and speed the delivery of material crucial to vaccine development processes.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

DECEMBER 22, 2022

The company is a clinical-stage biopharmaceutical startup that uses its artificial intelligence (AI)-enabled platform to measure brain biomarkers, including electroencephalogram (EEG) activity and behavioural patterns, wearable data, genetics and other factors, to drive targeted drug development in mental health.

Diabetes 52

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 26, 2008

It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

PharmaShots

FEBRUARY 21, 2023

The company is developing PPMX-T002, an anti-cancer drug with an antibody targeting CDH3 connected with a radioisotope yttrium 90 (90Y). Perseus has been discussing the collaborative development of PPMX-T002 with various RI medical drug-developing companies, including PeptiDream and its subsidiary PDRAdhiopharma.

Dosage 56

Dosage Labelling Immunization Immunity 56

Pharmaceutical Technology

JULY 23, 2008

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. ” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” “For certain cancers, yes,” says Ando.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 52

pharmaphorum

FEBRUARY 16, 2021

President Joe Biden asked Slaoui to step down as chief scientific adviser to the US COVID-19 vaccine initiative after the White House administration changed late last month and the former GlaxoSmithKline research chief wasted no time in finding a new project.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 59

Pharmaceutical Technology

APRIL 12, 2023

The Association of the British Pharmaceutical Industry (ABPI) also states that “the use of animals in medical research has played and continues to play an essential role in the development of new medicines and vaccines”. The topic of animal testing remains a fiercely contentious topic in the public eye.

Vaccines 98

Vaccines Biosimilars Communication Pharmaceutical Companies 98

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 20, 2023

We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ)

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52